Literature DB >> 28117597

Amino Acid Concentrations in HIV-Infected Youth Compared to Healthy Controls and Associations with CD4 Counts and Inflammation.

Thomas R Ziegler1, Suzanne E Judd2, Joshua H Ruff3, Grace A McComsey4, Allison Ross Eckard5,6.   

Abstract

Amino acids play critical roles in metabolism, cell function, body composition and immunity, but little data on plasma amino acid concentrations in HIV are available. We evaluated plasma amino acid concentrations and associations with CD4 counts and inflammatory biomarkers in HIV-infected youth. HIV-infected subjects with a high (≥500 cells/mm3) and low (<500 cells/mm3) current CD4+ T cell counts were compared to one another and to a matched healthy control group. Plasma concentrations of 19 amino acids were determined with an amino acid analyzer. Plasma levels of interleukin-6, tumor necrosis factor receptor-I, and soluble vascular cellular adhesion molecule-I were also measured. Seventy-nine HIV-infected subjects (40 and 39 with high and low CD4+ T cell counts, respectively) and 40 controls were included. There were no differences in amino acid concentrations between HIV-infected subjects with high or low CD4+ T cell counts. When combined, the HIV-infected group exhibited significantly lower median plasma concentrations compared to controls for total, essential, branched-chain and sulfur amino acids, as well as for 12 individual amino acids. Glutamate was the only amino acid that was higher in the HIV-infected group. There were no significant correlations between amino acid endpoints and inflammatory biomarkers for either HIV-infected group or controls. Plasma amino acid concentrations were lower in HIV-infected youth compared to healthy controls, regardless of immune status, while glutamate concentrations were elevated. These findings can inform future interventional studies designed to improve metabolic and clinical parameters influenced by amino acid nutriture.

Entities:  

Keywords:  CD4 count; HIV; amino acids; pediatrics

Mesh:

Substances:

Year:  2017        PMID: 28117597      PMCID: PMC5512337          DOI: 10.1089/AID.2015.0369

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  58 in total

Review 1.  Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.

Authors:  C Grunfeld; K R Feingold
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

2.  Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support.

Authors:  U Süttmann; J Ockenga; H Schneider; O Selberg; A Schlesinger; H Gallati; G Wolfram; H Deicher; M J Müller
Journal:  J Am Diet Assoc       Date:  1996-06

3.  Plasma glutathione of HIV⁺ patients responded positively and differently to dietary supplementation with cysteine or glutamine.

Authors:  Maria Dorotéia Borges-Santos; Fernando Moreto; Paulo Câmara Marques Pereira; Yong Ming-Yu; Roberto Carlos Burini
Journal:  Nutrition       Date:  2012-01-20       Impact factor: 4.008

4.  Elevated plasma glutamate concentrations in HIV-1-infected patients may contribute to loss of macrophage and lymphocyte functions.

Authors:  H P Eck; H Frey; W Dröge
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

5.  Effect of dietary protein depletion on nonspecific immune responses and survival in the guinea pig.

Authors:  J Sobrado; A Maiz; I Kawamura; L L Moldawer; B R Bistrian; G L Blackburn
Journal:  Am J Clin Nutr       Date:  1983-05       Impact factor: 7.045

6.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

7.  Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Authors:  Mohammad-Ali Jenabian; Mohamed El-Far; Kishanda Vyboh; Ido Kema; Cecilia T Costiniuk; Rejean Thomas; Jean-Guy Baril; Roger LeBlanc; Cynthia Kanagaratham; Danuta Radzioch; Ossama Allam; Ali Ahmad; Bertrand Lebouché; Cécile Tremblay; Petronela Ancuta; Jean-Pierre Routy
Journal:  J Infect Dis       Date:  2015-01-23       Impact factor: 5.226

8.  Plasma citrulline kinetics and prognostic value in critically ill patients.

Authors:  Gaël Piton; Cyril Manzon; Elisabeth Monnet; Benoit Cypriani; Olivier Barbot; Jean-Christophe Navellou; Franck Carbonnel; Gilles Capellier
Journal:  Intensive Care Med       Date:  2010-04       Impact factor: 17.440

9.  Plasma citrulline is a biomarker of enterocyte mass and an indicator of parenteral nutrition in HIV-infected patients.

Authors:  Pascal Crenn; Pierre De Truchis; Nathalie Neveux; Tatiana Galpérine; Luc Cynober; Jean Claude Melchior
Journal:  Am J Clin Nutr       Date:  2009-07-08       Impact factor: 7.045

10.  Protein and energy substrate metabolism in AIDS patients.

Authors:  T P Stein; C Nutinsky; D Condoluci; M D Schluter; M J Leskiw
Journal:  Metabolism       Date:  1990-08       Impact factor: 8.694

View more
  6 in total

1.  Evidence for Altered Glutamine Metabolism in Human Immunodeficiency Virus Type 1 Infected Primary Human CD4+ T Cells.

Authors:  Andrea Hegedus; Maia Kavanagh Williamson; Mariam B Khan; Julianna Dias Zeidler; Andrea T Da Poian; Tatiana El-Bacha; Eduard A Struys; Hendrik Huthoff
Journal:  AIDS Res Hum Retroviruses       Date:  2017-10-04       Impact factor: 2.205

2.  HIV infection and latency induce a unique metabolic signature in human macrophages.

Authors:  Paul Castellano; Lisa Prevedel; Silvana Valdebenito; Eliseo A Eugenin
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

3.  Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection.

Authors:  Flora Mikaeloff; Sara Svensson Akusjärvi; George Mondinde Ikomey; Shuba Krishnan; Maike Sperk; Soham Gupta; Gustavo Daniel Vega Magdaleno; Alejandra Escós; Emilia Lyonga; Marie Claire Okomo; Claude Tayou Tagne; Hemalatha Babu; Christian L Lorson; Ákos Végvári; Akhil C Banerjea; Julianna Kele; Luke Elizabeth Hanna; Kamal Singh; João Pedro de Magalhães; Rui Benfeitas; Ujjwal Neogi
Journal:  Commun Biol       Date:  2022-01-11

4.  Serum protein concentration and amino acid profile of HIV/HBV co-infected subjects on HAART in Plateau State, Nigeria.

Authors:  Chidi Uzoma Igwe; Emmanuel Emagba Ewuga; Cosmas Onyedikachi Ujowundu; Ignatius Oparaji Onyeocha; Viola Adaku Onwuliri
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

5.  Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy.

Authors:  Urvinder Kaur S; Bolaji Fatai Oyeyemi; Anita Shet; Bindu Parachalil Gopalan; Himanshu D; Neel Sarovar Bhavesh; Ravi Tandon
Journal:  PLoS One       Date:  2020-08-31       Impact factor: 3.240

6.  HIV-Infected Individuals on ART With Impaired Immune Recovery Have Altered Plasma Metabolite Profiles.

Authors:  Sofia Nyström; Melissa Govender; Siew Hwei Yap; Adeeba Kamarulzaman; Reena Rajasuriar; Marie Larsson
Journal:  Open Forum Infect Dis       Date:  2021-06-02       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.